Tyrian Diagnostics Limited (TDX) - Product Pipeline Analysis, 2016 Update

Report code: GDME6475PD

Publisher: GlobalData

Formats: PDF

Published: June 29, 2016

Number of pages: 22

Tyrian Diagnostics Limited (Tyrian Diagnostics) formerly Proteome Systems Limited is a medical equipment company that manufactures, and markets diagnostics for clinical and non-clinical applications. The company discovers and validates novel biomarkers for tuberculosis. It has developed a proprietary point of care diagnostics platform such as diagnostiQTM. Tyrian also develops various solutions for proteomics research. The company’s technology comprises small disposable plastic capsule and a USB-driven reader machine. It distributes its product through partnerships with various marketing and distribution companies. Tyrian Diagnostics is headquartered in Sydney, New South Wales, Australia.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Tyrian Diagnostics Limited

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Tyrian Diagnostics Limited Company Snapshot 5

Tyrian Diagnostics Limited Company Overview 5

Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6

Tyrian Diagnostics Limited – Pipeline Analysis Overview 8

Key Facts 8

Tyrian Diagnostics Limited - Major Products and Services 9

Tyrian Diagnostics Limited Pipeline Products by Development Stage 10

Tyrian Diagnostics Limited Pipeline Products Overview 12

Biomarker Test - Cystic Fibrosis 12

Biomarker Test - Cystic Fibrosis Product Overview 12

Prostate cancer diagnostic test using HCA 13

Prostate cancer diagnostic test using HCA Product Overview 13

Prostate Cancer Diagnostic Test using HCA 14

Prostate Cancer Diagnostic Test using HCA Product Overview 14

Second Generation TB POC Test 15

Second Generation TB POC Test Product Overview 15

Tyrian Diagnostics Limited - Key Competitors 16

Tyrian Diagnostics Limited - Key Employees 17

Tyrian Diagnostics Limited - Locations And Subsidiaries 18

Head Office 18

Recent Developments 19

Tyrian Diagnostics Limited, Recent Developments 19

Dec 19, 2011: Tyrian Signs Distribution Agreement For Tuberculosis Antibodies 19

Nov 24, 2011: Tyrian Diagnostics Announces Resignation Of Michael Vamos As CFO 19

Oct 15, 2009: Tyrian Seeks New Partner Opportunities For Tuberculosis Diagnostic Tests 19

Apr 30, 2009: Tyrian Announces Resignation Of Phillip Morley From Its Board 20

Nov 06, 2008: Proteome Systems Changes Its Name To Tyrian Diagnostics 20

Aug 29, 2008: Proteome Systems Reports Fiscal Year 2008 Results 20

Jul 16, 2008: Proteome Systems Reports Proof Of Concept Study Results For Prostate Cancer Diagnostic Program 20

Feb 29, 2008: Proteome Systems Reports 1H Fiscal 2008 Results 20

Jun 19, 2007: Proteome Systems Appoints New Directors 21

May 02, 2007: Proteome Systems Appoints New CEO 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22

List of Tables

List of Tables

Tyrian Diagnostics Limited Pipeline Products and Clinical Trials Overview 6

Tyrian Diagnostics Limited Pipeline Products by Equipment Type 6

Tyrian Diagnostics Limited Pipeline Products by Indication 7

Tyrian Diagnostics Limited, Key Facts 8

Tyrian Diagnostics Limited, Major Products and Services 9

Tyrian Diagnostics Limited Number of Pipeline Products by Development Stage 10

Tyrian Diagnostics Limited Pipeline Products Summary by Development Stage 11

Biomarker Test - Cystic Fibrosis - Product Status 12

Biomarker Test - Cystic Fibrosis - Product Description 12

Prostate cancer diagnostic test using HCA - Product Status 13

Prostate cancer diagnostic test using HCA - Product Description 13

Prostate Cancer Diagnostic Test using HCA - Product Status 14

Prostate Cancer Diagnostic Test using HCA - Product Description 14

Second Generation TB POC Test - Product Status 15

Second Generation TB POC Test - Product Description 15

Tyrian Diagnostics Limited, Key Employees 17

List of Figures

List of Figures

Tyrian Diagnostics Limited Pipeline Products by Equipment Type 7

Tyrian Diagnostics Limited Pipeline Products by Development Stage 10

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP